When researching enteral nutrition options, understanding the technical classification of specific formul Compleat Peptide 1.5 formula is a high-quality plant- and peptide-based tube feeding formula ...

Application represents an important step in supporting reimbursement Company remains on track for U.S. commercial launch of LYTENAVA before year-end 2026 ISELIN, N.J., Oct. 01, 2026 (GLOBE NEWSWIRE) - ...

Cervical cancer screening rates lagged behind in American Indian, Alaska Native, Native Hawaiian, and Pacific Islander ...

A coding or documentation error that reaches the payer can come back as a denial, and a denied claim has to be corrected or ...

ISELIN - Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA (bevacizumab-vikg, bevacizumab gamma) for the treatment of ...

Lantheus Holdings, Inc. (?Lantheus? or the ?Company?) (NASDAQ: LNTH) announced that the Centers for Medicare & Medicaid Services (?CMS?) has granted Transitional Pass-Through (?TPT?) payment status ...

Smart wound dressing market to grow from USD 118.7 Mn in 2026 to USD 824.0 Mn by 2036 at a 21.4% CAGR. Get segment, region & ...

When a retired carpenter in Washington chose Original Medicare to escape prior-authorization battles, he discovered a private AI vendor now screens his spine injection first, and what a lawsuit ...

UnitedHealthcare's October prior authorization cuts generated headlines about 1,700 procedures, but Medicare Advantage members searching for their scheduled procedure on that list are finding a very ...

Infertility and reproductive health conditions such as endometriosis, polycystic ovary syndrome, progesterone deficiency, insulin resistance, thyroid disease, and male-factor infertility affect ...

Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver ...